Pharmacogenomics in colorectal carcinoma
β
Antonio Russo; Simona Corsale; Patrizia Cammareri; Valentina Agnese; Sandra Casc
π
Article
π
2005
π
John Wiley and Sons
π
English
β 207 KB
## Abstract The recent introduction of new drugs such as capecitabine, irinotecan, and oxaliplatinum has greatly improved the clinical outcome of patients with advanced/metastatic colorectal cancer. Nevertheless, some patients may suffer from the adverse drug reactions which will probably be the ma